ClinicalTrials.gg
RecruitingNCT06557005Updated Jul 13, 2026

Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions

An interventional study of Facilitated Transition to Primary Care in Hypertension, Diabetes and Postpartum, sponsored by Massachusetts General Hospital. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-13.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started May 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,320
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 24 studies in Hypertension by Massachusetts General Hospital — 4 open to participants now, 4 under way, none of them phase 3. Hypertension · Massachusetts General Hospital.

Planned enrollment
2nd of 21
1,320 · median 80
Started
2025
with 2 others
No phase
18 of 24
2 open now
Registered
21st of 24
by date

Among the 24 studies in Hypertension by Massachusetts General Hospital, this one is the 2nd largest by planned enrollment of the 21 interventional ones that give a count, is one of 3 that started in 2025, is one of 18 with no phase, and was the 21st registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

Browse Hypertension studies →

Open to participants now

4 of the 24 studies in Hypertension by Massachusetts General Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Hypertension by Massachusetts General Hospital, or all of them as a file.
02

Study summary

The lack of postpartum primary care coordination is a missed opportunity to increase primary care engagement and manage chronic conditions early in life, especially for the >30% of pregnant people who have or are at risk for these conditions. This study aims to increase postpartum primary care engagement, quality, and experience by strengthening postpartum transitions to primary care using a behavioral economics-informed, multi-component intervention integrated into usual inpatient postpartum care. Using a randomized controlled trial and repeated outcome assessments through administrative and survey data, this study will generate rigorous, actionable evidence to ensure primary care coordination becomes standard postpartum care practice, potentially catalyzing sustained primary care engagement throughout life.

Read the detailed description

Over 30% of pregnant people have at least one chronic medical condition, and 20% have certain prenatal conditions (e.g., pregnancy-related hypertension, gestational diabetes) that increase the risk of chronic disease later in life. While patients with these conditions are typically highly engaged in prenatal care, they encounter a "postpartum cliff" in health system support after delivery; many receive no postpartum primary care at all despite having ongoing medical needs. At a time of increased stress, sleep deprivation, and competing demands, they must navigate administrative burdens in accessing primary care, often without scheduling assistance or any formal handoff between their obstetric and primary care clinician (PCP). These burdens may lead to avoided or delayed postpartum primary care, exacerbating health inequities that existed prenatally even for those fortunate enough to have a PCP. Given the many benefits of primary care, this lack of obstetric-to-primary care coordination represents a missed opportunity to increase primary care engagement and manage chronic conditions earlier in life. The primary objective is to increase postpartum primary care engagement, quality, and experience by strengthening obstetric-to-primary care coordination using a behavioral economics-informed intervention. The intervention, integrated into routine inpatient postpartum care, includes default PCP visit scheduling, tailored nudge messages to patients, ongoing care recommendations sent to the PCP, and a summary of recommendations after pregnancy given to the patient. Using a robust randomized controlled trial of 1,320 participants that is built off of the team's pilot study, the proposed study will: (Aim 1) measure the intervention's impact on postpartum primary care visit completion, sustained engagement, and disparities in these outcomes; (Aim 2) measure the intervention's impact on high-value primary care service use; and (Aim 3) measure the intervention's impact on patient experience. The study will generate rigorous, actionable evidence to ensure primary care coordination becomes standard postpartum care practice and will provide insight into postpartum patients' health care experiences. By targeting a vulnerable population at a time of great need and opportunity, postpartum-to-primary care coordination has the potential to catalyze sustained primary care engagement throughout life and improve long-term health.

03

Conditions studied

  • Hypertension
  • Diabetes
  • Postpartum
  • Pregnancy
  • Anxiety
  • Depression
  • Obesity

Keywords

  • Postpartum Care
  • Primary Care
  • Care Transitions
  • Chronic Disease
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Receiving obstetric care at an MGH-affiliated obstetrics practice (except for the MGH HOPE Clinic, which has a unique care model that provides prenatal and postnatal care for individuals with substance use disorder, including the provision of primary care through 2+ years postpartum)
  • Pregnant with a live fetus or delivered a live-born neonate ≥24 weeks of gestation, based on the clinical estimate of gestational age
  • If postpartum, has a neonate that is currently living at the time of enrollment
  • Has one or more of the following conditions listed in the "Problem List," "Medical History," or clinical notes during prenatal, intrapartum, or postpartum encounters in the EHR (or in the case of , the patient's anthropometric measurements):

    • Chronic or essential hypertension
    • Hypertensive disorders related to pregnancy (e.g., pre-eclampsia)
    • Type 1 or 2 diabetes (i.e., pre-existing diabetes)
    • Gestational diabetes
    • Class II Obesity (pre-pregnancy body mass index ≥35 kg/m2; or if pre-pregnancy body mass index is not known, a first trimester BMI of ≥35 kg/m2)
    • Depression or anxiety disorder
  • Has a primary care clinician listed in the patient's medical record
  • Has access to or agrees to be enrolled in the electronic health record patient portal and consents to be contacted via these modalities
  • Able to read/speak English or Spanish language
  • Is age ≥18 years old

Exclusion criteria

Exclusion Criteria

  • Any individual not meeting all inclusion criteria
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
1,320 participants (estimated)

Study arms

  • No intervention
    Routine Care

    Routine postpartum care

  • Active comparator
    Facilitated Transition Group

    The intervention is integrated into routine inpatient postpartum care and includes the following components: default PCP visit scheduling, tailored nudge messages to patients, ongoing care recommendations sent to the PCP, and a summary of recommendations after pregnancy given to the patient.

    Other: Facilitated Transition to Primary Care

Interventions

  • OtherFacilitated Transition to Primary Care

    The intervention includes default PCP visit scheduling, tailored nudge messages to patients, ongoing care recommendations sent to the PCP, and a summary of recommendations after pregnancy given to the patient.

06

What researchers measure

Primary outcomes

  1. Completion of a primary care visit

    Observation of a visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).

    Time frame: 155 days after date of delivery

  2. Receipt of condition-specific recommended health screening and counseling by a primary care practitioner

    For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as documented in the electronic health record. For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) in the electronic health record. For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as documented in the electronic health record. "

    Time frame: 155 days after date of delivery

  3. Self-report of having a known, reliable primary care practitioner

    The outcome is the Self-report of having a known, reliable primary care practitioner (doctor, nurse practitioner, or physician's assistant).

    Time frame: 155 days after date of delivery

  4. Self-report of mental health

    Edinburgh Perinatal Depression Scale will be administered and the total EPDS score compared.

    Time frame: 155 days after date of delivery

Secondary outcomes

  1. Completion of an annual exam with a primary care practitioner

    Observation of an annual exam or health care maintenance visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).

    Time frame: 155 days after date of delivery

  2. Self-report of completion of a primary care visit

    Self-report of a visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology) for any reason.

    Time frame: 155 days after date of delivery

  3. Self-report of an annual exam with a primary care practitioner

    Self-report of an annual exam or health care maintenance visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).

    Time frame: 155 days after date of delivery

  4. Completion of a primary care visit

    Observation of a visit with a primary care practitioner for any reason.

    Time frame: 365 days after date of delivery

  5. Self-report of completion of a primary care visit

    Self-report of a visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology) for any reason.

    Time frame: 365 days after date of delivery

  6. Completion of an annual exam with a primary care practitioner

    Observation of an annual exam or health care maintenance visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).

    Time frame: 365 days after date of delivery

  7. Self-report of an annual exam with a primary care practitioner

    Self-report of an annual exam or health care maintenance visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).

    Time frame: 365 days after date of delivery

  8. Repeated primary care practitioner engagement

    Observation of two or more primary care practitioner visits for any reason.

    Time frame: 365 days after date of delivery

  9. Self-report of repeated primary care practitioner engagement

    Self-report of two or more primary care practitioner visits for any reason.

    Time frame: 365 days after date of delivery

  10. Extent of primary care practitioner engagement

    Number of primary care practitioner visits for any reason.

    Time frame: 365 days after date of delivery

  11. Self-report of extent of primary care practitioner engagement

    Self-report of the number of primary care practitioner visits for any reason.

    Time frame: 365 days after date of delivery

  12. Completion of a primary care visit

    Observation of a visit with a primary care practitioner for any reason.

    Time frame: 548 days after date of delivery

  13. Completion of an annual exam with a primary care practitioner

    Observation of an annual exam or health care maintenance visit with a primary care practitioner.

    Time frame: 548 days after date of delivery

  14. Repeated primary care practitioner engagement

    Observation of two or more primary care practitioner visits for any reason.

    Time frame: 548 days after date of delivery

  15. Extent of primary care practitioner engagement

    Number of primary care practitioner visits for any reason.

    Time frame: 548 days after date of delivery

  16. Self-report of receipt of condition-specific recommended health screening and counseling by a primary care practitioner

    For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as reported by the participant. For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) as reported by the participant. For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as reported by the participant.

    Time frame: 155 days after date of delivery

  17. Receipt of recommended screening and counseling for chronic condition by primary care practitioner

    For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as documented in the electronic health record.

    Time frame: 155 days after date of delivery

  18. Receipt of recommended screening for gestational condition by primary care practitioner

    For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as documented in the electronic health record. For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) in the electronic health record."

    Time frame: 155 days after date of delivery

  19. Receipt of recommended screening and counseling for chronic condition by primary care practitioner

    For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as documented in the electronic health record.

    Time frame: 365 days after date of delivery

  20. Receipt of recommended screening for gestational condition by primary care practitioner

    For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as documented in the electronic health record. For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) in the electronic health record.

    Time frame: 365 days after date of delivery

  21. Receipt of recommended screening and counseling for chronic condition by primary care practitioner

    For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as documented in the electronic health record.

    Time frame: 548 days after date of delivery

  22. Receipt of recommended screening for gestational condition by primary care practitioner

    For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as documented in the electronic health record. For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) in the electronic health record.

    Time frame: 548 days after date of delivery

  23. Self-report of receipt of recommended screening and counseling for chronic condition by primary care practitioner

    For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as reported by the participant.

    Time frame: 365 days after date of delivery

  24. Self-report of receipt of recommended screening for gestational condition by primary care practitioner

    For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as reported by the participant. For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) as reported by the participant. "

    Time frame: 365 days after date of delivery

  25. Self-report of having a known, reliable primary care practitioner

    Participant report of having a known, reliable primary care practitioner (doctor, nurse practitioner, or physician's assistant).

    Time frame: 365 days after date of delivery

  26. Urgent or emergent care use

    Emergency department or urgent care visit for any reason as documented in the electronic health record.

    Time frame: 155 days after date of delivery

  27. Self-report of urgent or emergent care use

    Emergency department or urgent care visit for any reason as documented as reported by the participant.

    Time frame: 155 days after date of delivery

  28. Urgent or emergent care use

    Emergency department or urgent care visit for any reason as documented in the electronic health record.

    Time frame: 365 days after date of delivery

  29. Self-report of urgent or emergent care use

    Emergency department or urgent care visit for any reason as reported by the participant.

    Time frame: 365 days after date of delivery

  30. Self-report of mental health

    Edinburgh Perinatal Depression Scale score as reported by the participant.

    Time frame: 365 days after date of delivery

  31. Urgent or emergent care use

    Emergency department or urgent care visit for any reason as documented in the electronic health record.

    Time frame: 584 days after date of delivery

  32. Interpregnancy interval

    Defined as the time (in days) from date of delivery until subsequent date of conception.

    Time frame: 365 days after date of delivery

  33. Interpregnancy interval

    Defined as the time (in days) from date of delivery until subsequent date of conception.

    Time frame: 584 days after date of delivery

  34. Prescription or documentation of medication use for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder

    Observation of a prescription for or provider documentation noting the use of a medication for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder in the electronic health record.

    Time frame: 155 days

  35. Prescription or documentation of medication use for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder

    Observation of a prescription for or provider documentation noting the use of a medication for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder in the electronic health record.

    Time frame: 365 days

  36. Prescription or documentation of medication use for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder

    Observation of a prescription for or provider documentation noting the use of a medication for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder in the electronic health record.

    Time frame: 584 days

  37. Contraception use

    The use of any form of contraception as documented in the electronic health record

    Time frame: 155 days

  38. Contraception use

    The use of any form of contraception as documented in the electronic health record

    Time frame: 365 days

  39. Contraception use

    The use of any form of contraception as documented in the electronic health record

    Time frame: 584 days

  40. Self-report of contraception

    Self-report of using contraception or discussing family planning/contraception

    Time frame: 155 days

  41. Self-report of contraception

    Self-report of using contraception or discussing family planning/contraception

    Time frame: 365 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Data sets generated for this analysis will be preserved and shared publicly after planned primary and secondary analyses are completed by the research team or at the end of the award, whichever occurs last. Data will be preserved for at least 5 years after public posting to ensure outside investigators can access and use this information for related research. Study metadata, code, and a deidentified data set that includes all collected trial data will be publicly available, without restricted access, on the Harvard Dataverse Repository.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: Data and materials will be available after planned primary and secondary analyses are completed by the research team or at the end of the award, whichever occurs last (expected 08/2029). Data will be available and accessible for at least 5 years after posting.

Access criteria: Study metadata, code, and a deidentified data set that includes all collected trial data will be publicly available, without restricted access, on the Harvard Dataverse Repository

Data sharing details ↗ · dataverse.harvard.edu

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for May 2027, 24 months after the start.

Of 1,407 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 24 months is close to that.

Counting every sponsor, half of 1,502 studies reached it within 23 months; a quarter within 10 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 13, 2024
First posted
Aug 16, 2024
StartActual
May 23, 2025
Primary completionEst.
May 23, 2027
CompletionEst.
May 23, 2028
Last update
Jul 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06557005
Responsible party
Mark Clapp, MD MPH (Physician Investigator, Massachusetts General Hospital) — Principal investigator
First posted
Aug 16, 2024
Start date
May 23, 2025
Primary completion
May 23, 2027 (estimated)
Completion
May 23, 2028 (estimated)
Last update
Jul 13, 2026

Study contacts

Mark A Clapp, MD, MPH
Contact
mark.clapp@mgh.harvard.edu
617-726-2000
Mark A Clapp, MD, MPH
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion